236 related articles for article (PubMed ID: 31766600)
1. A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity.
Geisler J; Touma J; Rahbar A; Söderberg-Nauclér C; Vetvik K
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766600
[TBL] [Abstract][Full Text] [Related]
2. The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.
Kumar A; Tripathy MK; Pasquereau S; Al Moussawi F; Abbas W; Coquard L; Khan KA; Russo L; Algros MP; Valmary-Degano S; Adotevi O; Morot-Bizot S; Herbein G
EBioMedicine; 2018 Apr; 30():167-183. PubMed ID: 29628341
[TBL] [Abstract][Full Text] [Related]
3. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
4. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
Cho HI; Han H; Kim CC; Kim TG
J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
[TBL] [Abstract][Full Text] [Related]
5. Generation of Cytotoxic T Lymphocytes Specific for Human Cytomegalovirus Using Dendritic Cells In Vitro.
Cho HI; Han H; Kim CC; Kim TG
J Immunother (1991); 2001 May; 24(3):242-249. PubMed ID: 11395640
[TBL] [Abstract][Full Text] [Related]
6. The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits.
Moussawi FA; Kumar A; Pasquereau S; Tripathy MK; Karam W; Diab-Assaf M; Herbein G
Sci Rep; 2018 Aug; 8(1):12574. PubMed ID: 30135434
[TBL] [Abstract][Full Text] [Related]
7. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
Tabi Z; Moutaftsi M; Borysiewicz LK
J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
[TBL] [Abstract][Full Text] [Related]
9. Distinct Oncogenic Transcriptomes in Human Mammary Epithelial Cells Infected With Cytomegalovirus.
Haidar Ahmad S; Pasquereau S; El Baba R; Nehme Z; Lewandowski C; Herbein G
Front Immunol; 2021; 12():772160. PubMed ID: 35003089
[TBL] [Abstract][Full Text] [Related]
10. Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study.
Touma J; Pantalone MR; Rahbar A; Liu Y; Vetvik K; Sauer T; Söderberg-Naucler C; Geisler J
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992442
[No Abstract] [Full Text] [Related]
11. The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications.
Nauclér CS; Geisler J; Vetvik K
Oncotarget; 2019 Jul; 10(42):4333-4347. PubMed ID: 31303966
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic potential of human cytomegalovirus and breast cancer.
Herbein G; Kumar A
Front Oncol; 2014; 4():230. PubMed ID: 25202681
[TBL] [Abstract][Full Text] [Related]
13. The Human Cytomegalovirus, from Oncomodulation to Oncogenesis.
Herbein G
Viruses; 2018 Aug; 10(8):. PubMed ID: 30081496
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and Functional Differences between Human Herpesvirus 6- and Human Cytomegalovirus-Specific T Cells.
Fastenackels S; Bayard C; Larsen M; Magnier P; Bonnafous P; Seddiki N; Appay V; Gautheret-Dejean A; Sauce D
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996090
[TBL] [Abstract][Full Text] [Related]
15. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
Front Immunol; 2018; 9():2734. PubMed ID: 30524448
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells and HCMV cross-presentation.
Arrode G; Davrinche C
Curr Top Microbiol Immunol; 2003; 276():277-94. PubMed ID: 12797453
[TBL] [Abstract][Full Text] [Related]
17. U
Goodwin CM; Schafer X; Munger J
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
19. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells.
Cinatl J; Cinatl J; Vogel JU; Rabenau H; Kornhuber B; Doerr HW
Intervirology; 1996; 39(4):259-69. PubMed ID: 9078467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
